Medication adherence among acne patients: A review

Journal of Cosmetic Dermatology

Volumn 9, Issue 2, 2010, Pages 160-166

  Lott, Robert ^a   Taylor, Sarah L ^a   O'Neill, Jenna L ^a   Krowchuk, Daniel P ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Acne vulgaris; Adherence; Medical therapy; Quality of life

Indexed keywords

ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN; ERYTHROMYCIN; ISOTRETINOIN; RETINOIC ACID; ZINC;

ACNE; ADD ON THERAPY; ARTICLE; CORRELATION ANALYSIS; DOSAGE SCHEDULE COMPARISON; DRINKING BEHAVIOR; DRUG ABUSE; EDUCATIONAL STATUS; EMPLOYMENT; GENDER; GROUPS BY AGE; HEALTH STATUS; HUMAN; MEDLINE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING;

ACNE VULGARIS; HUMANS; MEDICATION ADHERENCE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 77954434946     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2010.00490.x     Document Type: Article

References (23)

1. Del Rosso JQ. Combination topical therapy in the treatment of acne. Cutis 2006, 2(Suppl 1):5-12.
2. Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998, 134:454-8.
3. Rapp SR, Feldman SR, Graham G. The Acne Quality of Life Index (Acne-QOLI): development and validation of a brief instrument. Am J Clin Dermatol 2006, 7:185-92.
4. Tan JK, Balagurusamy M, Fung K. Effect of quality of life impact and clinical severity on adherence to topical acne treatment. J Cutan Med Surg 2009, 13:204-8.
5. Eichenfield LF, Nighland M, Rossi AB. Phase 4 study to assess tretinoin pump for the treatment of facial acne. J Drugs Dermatol 2008, 7:1129-36.
6. Pawin H, Beylot C, Chivot M. Creation of a tool to assess adherence to treatments for acne. Dermatology 2009, 218:26-32.
7. Jones-Caballero M, Pedrosa E, Penas PF. Self-reported adherence to treatment and quality of life in mild to moderate acne. Dermatology 2008, 217:309-14.
8. Rapp DA, Brenes GA, Feldman SR. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol 2004, 151:183-9.
9. Baker M, Tuley M, Busdiecker FL. Adapalene gel 0.1% is effective and well tolerated in acne patients in a dermatology practice setting. Cutis 2001, 68(4 Suppl.):41-7.
10. Marazzi P, Boorman GC, Donald AE. Clinical evaluation of double strength isotrexin versus benzamycin in the topical treatment of mild to moderate acne vulgaris. J Dermatolog Treat 2002, 13:111-17.
11. Cunliffe WJ, Fernandez C, Bojar R. An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne. J Dermatolog Treat 2005, 16:213-8.
12. McEvoy B, Nydegger R, Williams G. Factors related to patient compliance in the treatment of acne vulgaris. Int J Dermatol 2003, 42:274-80.
13. Zaghloul SS, Cunliffe WJ, Goodfield MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol 2005, 152:1015-21.
14. Cook-Bolden F. Subject preferences for acne treatments containing adapalene gel 0.1%: results of the MORE trial. Cutis 2006, 78(1 Suppl.):26-33.
15. Balkrishnan R, Kulkarni AS, Cayce K. Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States. Cutis 2006, 77:251-5.
16. Yentzer BA, Alikhan A, Teuschler H. An exploratory study of adherence to topical benzoyl peroxide in patients with acne vulgaris. J Am Acad Dermatol 2009, 60:879-80.
17. Koehler AM, Maibach HI. Electronic monitoring in medication adherence measurement. Implications for dermatology. Am J Clin Dermatol 2001, 2:7-12.
18. Krejci-Manwaring J, McCarty MA, Camacho F. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol 2006, 54(5 Suppl.):S235-6.
19. Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol 2006, 7:231-6.
20. Kaymak Y, Taner E, Taner Y. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Int J Dermatol 2009, 48:41-6.
21. Thiboutot D, Dreno B, Layton A. Acne counseling to improve adherence. Cutis 2008, 81:81-6.
22. Wolf JE. Safety and tolerability in the MORE trial. Cutis 2006, 78(1 Suppl.):19-25.
23. Patel VB, Misra AN, Marfatia YS. Preparation and comparative clinical evaluation of liposomal gel of benzoyl peroxide for acne. Drug Dev Ind Pharm 2001, 27:863-9.